We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Chad Therapeutics, | AMEX:CTU | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
RNS Number:1660M Conister Trust PLC 10 June 2003 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company Conister Trust PLC 2. Name of director Gareth Alan Jones 3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest 4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) 5. Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s) 6. Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary 7. Number of shares / amount of stock acquired 8. Percentage of issued class 9. Number of shares/amount of stock disposed 10. Percentage of issued class 11. Class of security 12. Price per share 13. Date of transaction 14. Date company informed 15. Total holding following this notification 16. Total percentage holding of issued class following this notification If a director has been granted options by the company please complete the following boxes. 17. Date of grant 9 June 2003 18. Period during which or date on which exercisable Up to 8 June 2013 - see conditions (under Any additional information) 19. Total amount paid (if any) for grant of the option Nil 20. Description of shares or debentures involved: class, number 500,000 Ordinary 25p shares 21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 34 pence 22. Total number of shares or debentures over which options held following this notification 500,000 23. Any additional information Conditions include: --------------------- (i) The option will vest if (i) a share price of 50p is achieved within 5 years ie by 8 June 2008 or 80p within 10 years ie by 8 June 2013; and (ii) the Company makes an aggregate #1.5m in consolidated profit on ordinary activities before taxation in a period commencing on 1 January 2003 and ending not later than 31 December 2005 as recorded in the published interim and full year results, excluding any annual charge to profit in excess of the normal annualised pension cost as calculated in accordance with prevailing accounting standards. (ii) If the 50p share price target were to be achieved in less than 3 years from the date of grant, then 50% of the options will vest immediately, and the remaining 50% will vest 6 months later or 3 years from the date of grant, whichever is the earlier. In these circumstances, condition (i) (b) above does not apply. (iii) No options vesting and then exercised may be sold less than four years from the date of grant. (iv) The share price will be deemed to have been achieved only if the amount (either 50p or 80p) represents the mean average of the mid-market share price over 30 consecutive calendar days. 24. Name of contact and telephone number for queries Tracy Reeder, Company Secretary, 01624 694677 25. Name and signature of authorised company official responsible for making this notification Tracy Reeder, Company Secretary Date of Notification 10 June 2003 The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material. SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of company Conister Trust PLC 2. Name of director Peter James Scott Hammonds 3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest 4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) 5. Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s) 6. Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary 7. Number of shares / amount of stock acquired 8. Percentage of issued class 9. Number of shares/amount of stock disposed 10. Percentage of issued class 11. Class of security 12. Price per share 13. Date of transaction 14. Date company informed 15. Total holding following this notification 16. Total percentage holding of issued class following this notification If a director has been granted options by the company please complete the following boxes. 17. Date of grant 9 June 2003 18. Period during which or date on which exercisable Up to 8 June 2013 - see conditions (under Any additional information) 19. Total amount paid (if any) for grant of the option Nil 20. Description of shares or debentures involved: class, number 1,250,000 Ordinary 25p shares 21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 34 pence 22. Total number of shares or debentures over which options held following this notification 1,250,000 23. Any additional information Conditions include: --------------------- (i) The option will vest if (i) a share price of 50p is achieved within 5 years ie by 8 June 2008 or 80p within 10 years ie by 8 June 2013; and (ii) the Company makes an aggregate #1.5m in consolidated profit on ordinary activities before taxation in a period commencing on 1 January 2003 and ending not later than 31 December 2005 as recorded in the published interim and full year results, excluding any annual charge to profit in excess of the normal annualised pension cost as calculated in accordance with prevailing accounting standards. (ii) If the 50p share price target were to be achieved in less than 3 years from the date of grant, then 50% of the options will vest immediately, and the remaining 50% will vest 6 months later or 3 years from the date of grant, whichever is the earlier. In these circumstances, condition (i) (b) above does not apply. (iii) No options vesting and then exercised may be sold less than four years from the date of grant. (iv) The share price will be deemed to have been achieved only if the amount (either 50p or 80p) represents the mean average of the mid-market share price over 30 consecutive calendar days. 24. Name of contact and telephone number for queries Tracy Reeder, Company Secretary, 01624 694677 25. Name and signature of authorised company official responsible for making this notification Tracy Reeder, Company Secretary Date of Notification 10 June 2003 The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material. This information is provided by RNS The company news service from the London Stock Exchange RDSEAKKEFADDEFE
1 Year Chad Therapeutics Chart |
1 Month Chad Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions